Draft Guidance for Industry and Staff; Availability: Procedures for Handling Section 522 Postmarket Surveillance Studies
Document ID: FDA-2011-D-0514-0001
Comments
Total: 7
-
Advanced Medical Technology Association - Comment
Posted : 11/16/2011 ID :FDA-2011-D-0514-0003 Agency : FDA -
Nov 14,2011 11:59 PM ET
-
RTI Biologics, Inc. - Comment
Posted : 12/09/2011 ID :FDA-2011-D-0514-0004 Agency : FDA -
Nov 14,2011 11:59 PM ET
-
American College of Cardiology - Comment
Posted : 12/09/2011 ID :FDA-2011-D-0514-0005 Agency : FDA -
Nov 14,2011 11:59 PM ET
-
Johnson & Johnson - Comment
Posted : 12/09/2011 ID :FDA-2011-D-0514-0006 Agency : FDA -
Nov 14,2011 11:59 PM ET
-
Medical Imaging & Technology Alliance (MITA) - Comment
Posted : 12/09/2011 ID :FDA-2011-D-0514-0007 Agency : FDA -
Nov 14,2011 11:59 PM ET
-
Cook Group, Inc. - Comment
Posted : 12/09/2011 ID :FDA-2011-D-0514-0008 Agency : FDA -
Nov 14,2011 11:59 PM ET
-
Biomet, Inc. (Biomet) - Comment
Posted : 12/23/2011 ID :FDA-2011-D-0514-0011 Agency : FDA -
Nov 14,2011 11:59 PM ET